Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect in a few days, on January 31, 2022?

This regulation mandates that layperson summaries of clinical trials be submitted within 1 year of trial completion.

Why are clinical trial summaries important, you ask?

Because they improve health literacy, which is crucial to increasing trust in pharma.

Watch our latest video to learn more about clinical trial summaries and how your medical affairs team can make them part of your strategy.

Share this post

About the author

Cactus Life Sciences
+ posts

Cactus Life Sciences helps pharma, biotech, and medical device organizations worldwide with content strategy, development, and data. We work with medical affairs to disseminate insight-driven information to healthcare professionals, payors, and patients in a range of formats.